Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs

S Thakral, A Yadav, V Singh, M Kumar, P Kumar… - Ageing research …, 2023 - Elsevier
Abstract Alzheimer's disease (AD), also called senile dementia, is the most common
neurological disorder. Around 50 million people, mostly of advanced age, are suffering from …

The role of s-palmitoylation in neurological diseases: implication for zDHHC family

D Liao, Y Huang, D Liu, H Zhang, X Shi, X Li… - Frontiers in …, 2024 - frontiersin.org
S-palmitoylation is a reversible posttranslational modification, and the palmitoylation
reaction in human-derived cells is mediated by the zDHHC family, which is composed of S …

[HTML][HTML] In vivo and computational studies on sitagliptin's neuroprotective role in type 2 diabetes mellitus: implications for Alzheimer's disease

V Mani, M Arfeen - Brain Sciences, 2024 - mdpi.com
Background/Objectives: Diabetes mellitus (DM), a widespread endocrine disorder
characterized by chronic hyperglycemia, can cause nerve damage and increase the risk of …

Pharmacokinetic and molecular docking studies to pyrimidine drug using Mn3O4 nanoparticles to explore potential anti-Alzheimer activity

WS Shehab, HA Haikal, DA Elsayed, AF El-Farargy… - Scientific Reports, 2024 - nature.com
Alzheimer disease (AD) is the cause of dementia and accounts for 60–80% cases. Tumor
Necrosis Factor-alpha (TNF-α) is a multifunctional cytokine that provides resistance to …

Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment

U Shah, A Shah, S Patel, A Patel, M Patel… - CNS & Neurological …, 2023 - benthamdirect.com
Over the past 20 years, advances in the field of pathogenesis have inspired researchers to
look into novel pharmacological therapeutics that are more focused on the …

Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer's agents: design, synthesis and biological evaluation

A Nagani, M Shah, S Patel, H Patel, V Parikh, A Patel… - Molecular Diversity, 2024 - Springer
Multi-target directed ligands (MTDLs) have recently been popularized due to their
outstanding efficacy in combating the complicated features of Alzheimer's disease. This …

Interaction between resveratrol and SIRT1: role in neurodegenerative diseases

L Zhu, M Yang, L Fan, Q Yan, L Zhang, P Mu… - Naunyn-Schmiedeberg's …, 2024 - Springer
Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and
Huntington's disease, pose significant health challenges and economic burdens worldwide …

[HTML][HTML] The influence of selected antipsychotic drugs on biochemical aspects of Alzheimer's disease

M Podsiedlik, M Markowicz-Piasecka… - International Journal of …, 2022 - mdpi.com
The aim of this study was to assess the potency of selected antipsychotic drugs (haloperidol
(HAL), bromperidol (BRMP), benperidol (BNP), penfluridol (PNF), pimozide (PIM) …

Recent update on the development of leucine-rich repeat kinase 2 (LRRK2) inhibitors: A promising target for the treatment of Parkinson's disease

A Patel, S Patel, M Mehta, Y Patel… - Medicinal …, 2022 - benthamdirect.com
Parkinson's disease is a relatively common neurological disorder with incidence increasing
with age. Since current medications only relieve the symptoms and do not change the …

Homalothecium philippeanum (Spruce) Schimp.(Bryophyta) ekstresinin Asetilkolinesteraz enzim aktivitesine etkisi

U Değirmenci, T Ezer - … Üniversitesi Tıp Fakültesi Lokman Hekim Tıp …, 2024 - dergipark.org.tr
Objective: Alzheimer's disease is the most common neurological disorder, affecting
approximately 50 million people. According to the cholinergic hypothesis, the decrease in …